Michaela Bazo
Co-founder of Metanova Labs and a builder on Bittensor's Subnet 68 for drug discovery. Focuses on using decentralized incentive systems to improve molecular screening and biotech R&D.
Best podcasts with Michaela Bazo
Ranked by the Snipd community
91 snips
Mar 26, 2026 • 1h 13min
This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267
Michaela Bazo, Metanova Labs co-founder, and Pedro Penna, technical lead in decentralized biotech, dive into Bittensor-powered drug discovery and the race to cut screening costs. Tom Bliers, BitCast Network co-founder, explores paying creators for watch time and branded videos. Max Septi, Score founder, shows how tiny vision AI models can make real-world deployment cheaper and faster.
12 snips
Jul 15, 2025 • 36min
Subnet Session with Michaela Bazo, CEO of Metanova: Rewiring Drug Discovery with SN68
Michaela Bazo, CEO of Metanova, is at the forefront of revolutionizing drug discovery with the first decentralized screening platform on Bittensor. She discusses how Metanova leverages an AI-driven network to screen millions of molecules more efficiently and affordably. The conversation dives into targeting behavioral drugs, the impact of decentralization on R&D, and potential big pharma partnerships. Michaela also reveals plans for wet lab validation and the transition to a token-based revenue model, highlighting a promising future for biotech innovation.
